ImmunotherapyHead and Neck Cancer
Meg Barbor, MPH
/ June 10, 2019
/ 2019 AACR-AHNS Head and Neck Cancer Conference
Programmed cell death protein 1 (PD-1) inhibitors are approved for the second-line treatment of head and neck cancer and likely will be soon in the first-line treatment of locally advanced disease. Ac...